Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Eli Lilly introduces physician payment registry for public

Eli Lilly and Company today announced the launch of a physician payment registry to help the public better understand how the company works with U.S. physicians and compensates them for their services – and how these collaborations benefit patient care.

28 Jul 2011

Mitochondrial genome undergoes random reorganisation during reprogramming

Induced pluripotent stem cells (iPS cells) are truly talented multi-taskers. They can reproduce almost all cell types and thus offer great hope in the fight against diseases like Alzheimer's and Parkinson's. However, it would appear that their use is not entirely without risk: during the reprogramming of body cells into iPS cells, disease-causing mutations can creep into the genetic material.

28 Jul 2011

Chronic psychological stress linked to increased risk of Alzheimer's

Chronic psychological stress throughout a lifespan might increase an individual's risk for Alzheimer's and dementia later in life, according to research from the Emma Eccles Jones College of Education and Human Services at Utah State University.

28 Jul 2011

Cognitive behavioral therapy and self-help may improve unexplained symptoms of pain, fatigue

A new type of therapy may help people with symptoms such as pain, weakness, or dizziness that can't be explained by an underlying disease, according to a study published in the July 27, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

28 Jul 2011

New research shows unique nature of human brain aging

Brains shrink in humans, potentially causing a number of health problems and mental illnesses as people age, but do they shrink to the same extent in the closest living relatives to humans--the chimpanzees? New research says no, making the extreme amount of brain shrinkage resulting from normal aging in humans unique.

28 Jul 2011

All football players do not get chronic traumatic encephalopathy

Preliminary results from the first four brains donated to the Canadian Sports Concussion Project at the Krembil Neuroscience Centre, TorontoWesternHospital, reveal that two of the four former Canadian Football League (CFL) players suffered from a brain disease known as Chronic Traumatic Encephalopathy (CTE), while two did not show signs of CTE.

27 Jul 2011

Positive data from two GSK's Promacta Phase III studies on hepatitis C-related thrombocytopenia

Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has announced that it received positive data from ENABLE-1, the first of two Phase III studies examining Promacta in patients with hepatitis C-related thrombocytopenia, and that full data will be released at an upcoming scientific conference.

27 Jul 2011

Anavex presents data on neuroprotective evidence for lead compound for Alzheimer’s

Anavex Life Sciences Corp. is pleased to provide a summary of its second poster presentation at the Alzheimer’s Association International Conference (AAIC) held in Paris, entitled “Preclinical development of new tetrahydrofuran derivatives targeting the sigma-1 chaperone protein as neuroprotectants in Alzheimer’s disease.”

26 Jul 2011

Specific yeast protein can promote spontaneous prion formation

It's a chicken and egg question. Where do the infectious protein particles called prions come from? Essentially clumps of misfolded proteins, prions cause neurodegenerative disorders, such as mad cow/Creutzfeld-Jakob disease, in humans and animals.

25 Jul 2011

UCSF, Kaiser Permanente achieve first major milestone in genomics project

One of the nation's largest and most diverse genomics projects has reached its first major milestone in just 15 months. Scientists have genotyped the DNA and analyzed the length of chromosome tips in more than 100,000 Kaiser Permanente members who agreed to be part of the research.

22 Jul 2011

Renowned neurosurgeon to receive National Urban League's highest honor on July 30

Renowned neurosurgeon Keith L. Black, MD, will receive the National Urban League's highest honor on July 30 during the organization's annual conference in Boston.

22 Jul 2011

Microencapsulated cell transplant can help treat chronic illnesses more effectively

Chronic illnesses such as Alzheimer's or Parkinson's could be treated more effectively in the future, by means of the transplant of microencapsulated cells. The researcher from the University of the Basque Country (UPV/EHU) Dr Ainhoa Murua has presented a number of proposals for optimising this technique.

21 Jul 2011

Experts present new research at 2011 Alzheimer's Association ICAD

Experts from the Center of Excellence on Brain Aging at NYU Langone Medical Center will present new research at the 2011 Alzheimer's Association International Conference on Alzheimer's disease to be held in Paris, France from July 16 - 21.

21 Jul 2011

Majority of people in the U.S., Europe express desire to seek early diagnosis of AD

Results of an international survey reveal that over 85% of respondents in the five countries surveyed say that if they were exhibiting confusion and memory loss, they would want to see a doctor to determine if the cause of the symptoms was Alzheimer's disease. Over 94% would want the same if a family member were exhibiting the symptoms.

21 Jul 2011

Excess brain activity in aMCI patients contributes to brain dysfunction underlying memory loss

An existing anti-seizure drug improves memory and brain function in adults with a form of cognitive impairment that often leads to full-blown Alzheimer's disease, a Johns Hopkins University study has found.

21 Jul 2011

Inherited forms of Alzheimer's could be detected long before memory problems develop

Inherited forms of Alzheimer's disease may be detectable as many as 20 years before problems with memory and thinking develop, scientists will report July 20, 2011, at the Alzheimer's Association International Conference on Alzheimer's Disease in Paris.

21 Jul 2011

Study examines cost-effectiveness of MS drugs in the U.S.

A new study examining the cost-effectiveness of drugs to treat multiple sclerosis (MS) in the United States finds that the health gains from these drugs come at a very high cost compared to basic therapy to control the symptoms of MS and compared to treatments for other chronic diseases.

21 Jul 2011

Alzheimer's Disease News and Research

Further Reading

Eli Lilly introduces physician payment registry for public

Mitochondrial genome undergoes random reorganisation during reprogramming

Chronic psychological stress linked to increased risk of Alzheimer's

Cognitive behavioral therapy and self-help may improve unexplained symptoms of pain, fatigue

New research shows unique nature of human brain aging

All football players do not get chronic traumatic encephalopathy

Positive data from two GSK's Promacta Phase III studies on hepatitis C-related thrombocytopenia

Anavex presents data on neuroprotective evidence for lead compound for Alzheimer’s

Specific yeast protein can promote spontaneous prion formation

UCSF, Kaiser Permanente achieve first major milestone in genomics project

Renowned neurosurgeon to receive National Urban League's highest honor on July 30

Microencapsulated cell transplant can help treat chronic illnesses more effectively

Experts present new research at 2011 Alzheimer's Association ICAD

Majority of people in the U.S., Europe express desire to seek early diagnosis of AD

Excess brain activity in aMCI patients contributes to brain dysfunction underlying memory loss

Inherited forms of Alzheimer's could be detected long before memory problems develop

Study examines cost-effectiveness of MS drugs in the U.S.

Three flutemetamol clinical abstracts to be presented at 2011 Alzheimer's Association ICAD

Bristol-Myers Squibb announces results of BMS-708163 Phase II study on Alzheimer's

PrioNet Canada awards University of Western Ontario $600,000 to study neurodegenerative disorders

Aneuro: A Year of Neuroscience in Review eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News